Diamyd, Medical

Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Diamyd Medical AB Sweden

en | boerse | 67919953 |